Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MLYCD | O95822 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12788597 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1TSHRMAPK1KDM4E | |
| SCHEMBL9680431 | 0.69 | ALDH1A1 (0.58) | SMN1; SMN2ALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL1706642 | 0.69 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1TSHRMAPK1USP2 | |
| SCHEMBL12928715 | 0.69 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1TSHRMAPK1USP2 | |
| SCHEMBL13052083 | 0.68 | OPRM1 (0.43) | SMN1; SMN2ALDH1A1TSHRMAPK1POLB | |
| SCHEMBL11923112 | 0.68 | MAPT (0.41) | SMN1; SMN2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL12156461 | 0.68 | KDM4E (0.47) | SMN1; SMN2ALDH1A1TSHRMAPK1KDM4E | |
| Hydrochloric Acid SCHEMBL25407374 | 0.67 | ALDH1A1 (0.47) | SMN1; SMN2ALDH1A1TSHRMAPK1USP2 | |
| SCHEMBL4256867 | 0.67 | ALDH1A1 (0.47) | SMN1; SMN2ALDH1A1TSHRMAPK1USP2 | |
| SCHEMBL31302979 | 0.67 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1TSHRMAPK1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2664629-B1 | Functionalised photoinitiators | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-1711862-B1 | FUNCTIONALIZED PHOTOINITIATORS | BASF SE (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-2664629-A1 | Functionalised photoinitiators | Ciba Holding Inc. (CH) | 2013-11-20 | — | — | EP | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| EP-1711862-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005076074-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-08-18 | — | — | WO | disclosed |
| US-20040068110-A1 | Novel morpholinoketone derivatives, and preparation process and uses of the same | CHIU CHINGFAN CHRIS | 2004-04-08 | — | — | US | disclosed |
| US-20030225179-A1 | Novel morpholinoketone derivatives, and preparation process and uses of the same | CHIU CHINGFAN CHRIS | 2003-12-04 | — | — | US | disclosed |
| EP-1357117-A2 | Novel aminoketone derivatives and preparation process and uses of the same as photoinitiators | Chiu, Chingfan Chris (TW) | 2003-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021126-A1 | Functionalized Photoinitiators | PPOX, TYR, CYP1A1 | SMN1; SMN2 4226/4885ALDH1A1 39/4885TSHR 2434/4885 |
| US-20030225179-A1 | Novel morpholinoketone derivatives, and preparation process and uses of the same | MITF, DHPS, DTYMK | SMN1; SMN2 1672/4885ALDH1A1 1250/4885TSHR 4814/4885 |
| US-20040068110-A1 | Novel morpholinoketone derivatives, and preparation process and uses of the same | MITF, DHPS, DTYMK | SMN1; SMN2 1672/4885ALDH1A1 1250/4885TSHR 4814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.